BIC (BB) AGM 2026 summary

Opening remarks and agenda

• The meeting opened with tributes and introductions of the new Chair and CEO, outlining the agenda and confirming quorum at 85.88% of share capital represented, with key topics including 2025 results, sustainable development, and 2026 outlook.

Financial performance review

• FY 2025 net sales were EUR 2,090 million, down 0.9% like-for-like; organic growth declined 4.7% excluding scope effects.

• Adjusted EBIT margin was 13.6% (EUR 283 million); adjusted EPS was EUR 4.74, and free cash flow reached EUR 222 million.

• Net income group share dropped to EUR 86 million, impacted by non-recurring items including asset disposals and business discontinuations.

• Q1 2026 net sales were EUR 453 million, up 1.6% organically, with growth in all major regions except the Middle East and Africa, driven by strong US and Tangle Teezer performance.

• Divisional performance: Blade Excellence grew 15.7% (mainly from Tangle Teezer), Human Expression and Flame for Life divisions declined.

Board and executive committee updates

• Rob Versloot was appointed CEO in September 2025, following a structured succession process.

• The Board comprised 12 directors, with 60% women, and high attendance rates; several new directors were co-opted and ratified.

• Executive Committee renewed, reinforcing governance and organizational structure.

• Board held 13 meetings in 2025 with 93% attendance, focusing on strategy, financials, and governance transition.

• A new shareholders' agreement was established, reaffirming long-term family commitment.